IMMP IMMP
Company Profile ↓Company Overview
IMMP (IMMP) is a publicly traded company listed on with a market capitalization of $566.52M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -77.59% |
| 6 Months: | -86.14% |
| 3 Months: | -14.74% |
| 1 Month: | -12.84% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.99 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 87.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 170.37K | 0 | 0 | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 34.01M | 41.43M | 46.56M | - |
| Operating Income | -33.84M | -41.43M | -46.56M | - |
| EBITDA | -32.12M | -39.88M | -42.69M | - |
| Interest Expense | 92.43K | 20.40K | 30.59K | - |
| Pretax Income | -32.21M | -39.90M | -42.72M | - |
| Tax Provision | 34 | 0 | 0 | - |
| Net Income | -32.21M | -39.90M | -42.72M | - |
| Diluted EPS | -0.37 | -0.45 | -0.36 | -0.42 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Total Assets | 102.17M | 147.45M | 201.58M |
| Current Assets | 90.81M | 134.97M | 191.35M |
| Cash & Equivalents | 80.00M | 123.42M | 161.79M |
| Inventory | - | - | - |
| Receivables | 17.36K | 130.68K | 5.24K |
| Total Liabilities | 8.09M | 10.98M | 12.06M |
| Current Liabilities | 6.41M | 9.77M | 10.49M |
| Long Term Debt | 1.45M | 835.45K | 960.76K |
| Total Debt | 1.73M | 1.23M | 1.59M |
| Total Equity | 94.08M | 136.47M | 189.52M |
| Shares Outstanding | 888.01M | 1.20B | 1.45B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Operating Cash Flow | -43.94M | - | - |
| Investing Cash Flow | -22.91K | -82.73K | -21.02M |
| Financing Cash Flow | 50.33M | 76.02M | 95.18M |
| Capital Expenditure | -22.91K | -82.73K | -932.37K |
| Free Cash Flow | -30.25M | -35.44M | -35.75M |
| Net Change in Cash | 20.07M | 40.58M | 39.34M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | -19,861.2% | - | - | - |
| Net Margin % | -18,906.5% | - | - | - |
| ROE % | -34.2% | -29.2% | -22.5% | - |
| ROCE % | -35.3% | -30.1% | -24.4% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IMMP
IMMP | Immutep Limited American Depositary Analyst Forecasts - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9WU2lGSUtIOTdrUmNoRDJkMTJtTkJWbC1FMENmd3NtR0h1Qm9vT1h3WVFiVVJZN01YVlBjQ1VHaUhPUFJLU2YtSnozbDVLVmVscWNUYzlmWG9Dc0dK?oc=5" target="_blank">IMMP | Immutep Limited American Depositary …
Immutep (NASDAQ: IMMP) ends lung trial, extends cash runway - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQOGw3OC1nSmpXZjI2ZHhMeHlUNWI1RjBOUkxZS0JxSU9KdWJiakZ1bDJ1Z3VWZ0M5MVhSb3BCUGxhYzF1M0gtQUpOX2o3bEFBVGU3eDVMc2xYelBmNmpnVzZIWmMxNzM5UlQzSWFIMTRRaTBVN0RuU2VKQ3BVNGFqcHhJeUVpdVcwRV9YQi…
IMMP|Immutep Ltd|Price:0.390|Chg%:+0.010 - TradingKey
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE9OcU1SMWV5bUdpUXZHaXg3X3ZMY29qdUJ1U2tobXpHU0cyMlpXeGJZN0ZVYzQ4clJfRTBiOGRGa0lneW9XT0VsM1hEelNGdlQ0TmVHSnVrWTFwQQ?oc=5" target="_blank">IMMP|Immutep Ltd|Price:0.390|Chg%:+0.010</a>&…
IMMP Investor Alert: Immutep Ltd. Securities Fraud Investigation - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Failed To Disclose Material Risks Related To Trial Viability : Levi & Korsinsky - PR Newswire
<a href="https://news.google.com/rss/articles/CBMijwNBVV95cUxPeVdlRTVPalNHWHF5amZaT2pGcU9KUURFVjJyU0RzaF9feTdDRDJuaTNZZ1h0ck04d0N3WDBiU05xVS1JSWRpZk5FNEFTS01PcmhDT2J3bUVYVngwRUVNbGRKUU9SVzI4ajJ6TlZSNDRTZS1VQ1BJMXp2SU5sdjVTTXZvenVTWWVzWC1jOU…
IMMUTEP LIMITED INVESTORS WITH LOSSES HAVE UNTIL JULY 6, - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMirwJBVV95cUxPUmhZcDU4Y0NmNWNQcjN0UzVMYjl5MExYSHhGcnluUDlEZ2VWc0xGQXhaOUt4SmxHNXEwODhyd09mbE1fSEw3ZlNKdUhoT0pTcHhzdnRiQ1NicTJwRTVXTjFMd0VSbC1wWFBxNTh5eDkydHpXSzhoN3J3T05UQWluV3B2NURNSkViNnFucm…
Why Is This Beaten-Down Biotech Surging 150% In Pre-Market Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPMkpJdTJUMVg5c1JFeXE4LW84N3RKWmtGUkdGdXV1WVVhRk9jbUg2eEJXdEVEUkJ0NnBSbUpQNmZPSEluSnBScW1PX25PX2o3LVBUcGU4dnZvMDBDS0wyRWlrUDUzb0ZyNHI1aThsZHc2NjY3UHktMDJ1Z1ZwS1dhbWhjekctYktjYm4xZz…
IMMP — Frequently Asked Questions
What is the current share price of IMMP?
As of 2026-08-05 17:25 PDT, IMMP trades at $0.39 on NASDAQ/NYSE. Its 52-week range is $0.31 to $3.18.
What is the market capitalisation of IMMP?
IMMP has a market capitalisation of $566.52M on NASDAQ/NYSE.
What is the P/E ratio of IMMP?
IMMP trades at a trailing price-to-earnings (P/E) ratio of -0.92. Its price-to-book (P/B) ratio is 2.99.
What is the return on equity (ROE) of IMMP?
IMMP has a return on equity (ROE) of -22.54%. Its return on capital employed (ROCE) is -24.36%.
Is IMMP a good stock to buy?
This page provides a data-driven analysis of IMMP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.